EMPAGEN TRIO 12.5/2.5/1000MG TAB

Empagen Trio is a combination tablet containing empagliflozin, linagliptin, and metformin. This triple-action formulation addresses multiple pathways in glucose metabolism, making it suitable for patients with type 2 diabetes requiring comprehensive glycemic control. The synergistic combination helps reduce blood sugar levels while supporting cardiovascular and renal protection. Ideal for patients inadequately controlled on dual therapy or as an alternative to multiple individual medications.